New evidence suggests conducting screening colonoscopies for people in their mid- 50s saves money. But other evidence indicates there may be an upper age limit for the benefits of such screening.
New evidence suggests conducting screening colonoscopies for people in their mid- 50s saves money. But other evidence indicates there may be an upper age limit for the benefits of such screening.
Dr. Jianjun Li and colleagues from Maimonides Medical Center in Brooklyn conducted free screening colonoscopies for 248 consecutive patients with a mean age of 55. Follow-up detected colon cancer and large polyps in about one in 10.The screening program cost $390,000. Had these patients not been screened, their delayed treatment would have cost Medicare nearly $1.3 million. Li released results at the 2008 American College of Gastroenterology meeting.
On the other hand, the U.S. Preventive Services Task Force, an independent panel of the Department of Health and Human Services, recommended that screening cease when men reach age 75, when the possible harm from screening outweighs its benefits. The task force report was published in the Annals of Internal Medicine (2008;149[3]: 185-191).
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.